Current Drugs, Ltd. Announces DrugNet.Com

Information Today, February 1999 | Go to article overview

Current Drugs, Ltd. Announces DrugNet.Com


Current Drugs, Ltd. has announced the forthcoming availability of DrugNet.com, a new Internet-based service for the international pharmaceutical and biotechnology industries. DrugNet.com will integrate specialist databases, decision support software, and competitor intelligence services from a range of publishers and software vendors servicing the biomedical and pharmaceutical sector.

According to the announcement, DrugNet.com addresses the growing need to support and enhance the knowledge management and competitor intelligence activities of companies engaged in pharmaceutical research and development. Recognizing that companies need to access information from a wide range of public and privately held databases to support these activities, DrugNet.com allows them to mix and match a range of pre-built components for searching and hyperlinking databases with tools to analyze the information from a competitive intelligence perspective.

Commenting on the new service, Ian Tarr, managing director of Current Drugs, Ltd., said: "DrugNet.com answers the need, often cited by the pharmaceutical industry, for a system which brings together both data and data analysis tools that are specifically focused on this industry's requirements. We have worked closely with our pharmaceutical customers to identify the most important information sources from their standpoint and to develop the tools necessary to mine and analyze information from those sources."

"We already have a successful customization program that gives subscribers to the intranet version of our Investigational Drugs database (IDdb) the ability to extend its native functionality and its content in this way. With DrugNet.com, we will be making much of this more generally available via the Internet, which will particularly benefit the small-to-mediumsized company sector," said Tan.

Using the DrugNet.com site, a company will be able to assess the strategic focus of a competitor (or potential partner) and monitor its ongoing activities:

* Accessing information on its R&D pipeline from a selection of R&D monitoring services, bibliographic databases, and bioinformatics resources

* Mapping its intellectual property portfolio by extracting high-level data from specialist patent databases

* Analyzing its financial performance by mining data from key financial databases

* Assessing sales forecasts for its current and future product ranges from leading market analysis

* Drawing on expert knowledge held in specialist reviews and evaluations from leading scientific opinion makers and industry commentators

* Obtaining instant access to breaking news via aggregated real-time news feeds

* Creating both detailed reports and statistical and graphical analyses of research outcomes via a suite of Competitor Intelligence tools

* Tapping into and managing knowledge held within their own company through a structured, knowledge-sharing environment

DrugNet. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Current Drugs, Ltd. Announces DrugNet.Com
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.